ES2395740T8 - Composiciones que comprenden estroncio y usos de las mismas en el tratamiento o prevención de la gingivitis, la periodontitis, la periodontitis como una manifestacioón de enfermedades sistémicas y las enfermedades peridontales necrotizantes - Google Patents

Composiciones que comprenden estroncio y usos de las mismas en el tratamiento o prevención de la gingivitis, la periodontitis, la periodontitis como una manifestacioón de enfermedades sistémicas y las enfermedades peridontales necrotizantes Download PDF

Info

Publication number
ES2395740T8
ES2395740T8 ES07817968T ES07817968T ES2395740T8 ES 2395740 T8 ES2395740 T8 ES 2395740T8 ES 07817968 T ES07817968 T ES 07817968T ES 07817968 T ES07817968 T ES 07817968T ES 2395740 T8 ES2395740 T8 ES 2395740T8
Authority
ES
Spain
Prior art keywords
periodontitis
diseases
necrotizing
gingivitis
manifestation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07817968T
Other languages
English (en)
Other versions
ES2395740T3 (es
Inventor
John Nikolaj Hvarre Christensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Strontin ApS
Mokwalo Spf S A
MOKWALO SPF SA
Original Assignee
Strontin ApS
Mokwalo Spf S A
MOKWALO SPF SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Strontin ApS, Mokwalo Spf S A, MOKWALO SPF SA filed Critical Strontin ApS
Application granted granted Critical
Publication of ES2395740T3 publication Critical patent/ES2395740T3/es
Publication of ES2395740T8 publication Critical patent/ES2395740T8/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Birds (AREA)
ES07817968T 2006-11-21 2007-11-20 Composiciones que comprenden estroncio y usos de las mismas en el tratamiento o prevención de la gingivitis, la periodontitis, la periodontitis como una manifestacioón de enfermedades sistémicas y las enfermedades peridontales necrotizantes Active ES2395740T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK200601522 2006-11-21
DKPA200601522 2006-11-21
PCT/DK2007/050172 WO2008061535A1 (en) 2006-11-21 2007-11-20 Compositions comprising strontium and uses thereof in the treatment or prevention of gingivitis, periodontitis, periodontitis as a manifestation of systemic diseases, and necrotizing periodontal diseases.

Publications (2)

Publication Number Publication Date
ES2395740T3 ES2395740T3 (es) 2013-02-14
ES2395740T8 true ES2395740T8 (es) 2013-12-13

Family

ID=39099797

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07817968T Active ES2395740T3 (es) 2006-11-21 2007-11-20 Composiciones que comprenden estroncio y usos de las mismas en el tratamiento o prevención de la gingivitis, la periodontitis, la periodontitis como una manifestacioón de enfermedades sistémicas y las enfermedades peridontales necrotizantes

Country Status (7)

Country Link
US (2) US20100272802A1 (es)
EP (1) EP2097137B1 (es)
DK (1) DK2097137T3 (es)
ES (1) ES2395740T3 (es)
PL (1) PL2097137T3 (es)
PT (1) PT2097137E (es)
WO (1) WO2008061535A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110097372A1 (en) * 2009-10-26 2011-04-28 Rucinski Paul J Devices, methods, and compositions for controlling infections
NL2004260C2 (en) * 2010-02-18 2011-08-22 Univ Amsterdam Disinfectant composition and its use in dental treatment.
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis
CN114028327B (zh) * 2021-12-24 2023-09-12 西岭(镇江)医疗科技有限公司 一种含依克多因和氯化锶口腔用中药抑菌凝胶及其制备、使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3988434A (en) * 1972-08-07 1976-10-26 Schole Murray L Dental preparation
US5380530A (en) * 1992-12-29 1995-01-10 Whitehill Oral Technologies Oral care composition coated gum
US5641747A (en) * 1994-07-25 1997-06-24 Temple University-Of The Commonwealth System Of Higher Education Treatment of osteopetrotic diseases
WO1998033494A1 (en) * 1997-02-04 1998-08-06 Kosbab John V Compositions and methods for prevention and treatment of vascular degenerative diseases
AUPP494798A0 (en) * 1998-07-29 1998-08-20 Pacific Biolink Pty Limited Protective protein formulation
US20040053968A1 (en) * 2001-12-28 2004-03-18 Hartman George D. Methods and compositions for treating peridontal disease
US20060216358A1 (en) * 2003-05-07 2006-09-28 Christian Hansen Controlled release composition containing a strontium salt
WO2006000224A2 (en) * 2004-06-25 2006-01-05 Strontin Aps Compositions comprising strontium and vitamin d and uses thereof

Also Published As

Publication number Publication date
ES2395740T3 (es) 2013-02-14
PL2097137T3 (pl) 2013-02-28
WO2008061535A1 (en) 2008-05-29
EP2097137B1 (en) 2012-09-19
US20100272802A1 (en) 2010-10-28
DK2097137T3 (da) 2013-01-14
PT2097137E (pt) 2013-01-08
EP2097137A1 (en) 2009-09-09
US20170157001A1 (en) 2017-06-08

Similar Documents

Publication Publication Date Title
HN2008000188A (es) 7- aza- indazoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y su utilizacion
CR20110609A (es) Composicion antimicrobiana y metodos relacionados de uso
CO6440531A2 (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
DE112007000745A5 (de) Die Tornadormaschine - Ein Nebel-Wirbler, der als Effektgerät, Luftbefeuchter und Aerosolgenerator einsetzbar ist
CL2008000893A1 (es) Composición para el cuidado bucal que comprende una cantidad efectiva de un aminoácido básico y un agente antibacteriano; uso en el tratamiento antibacteriano de la cavidad bucal.
BRPI0818625A2 (pt) Composições de cuidados pessoais que compreendem sulfatos de undecila
CR11581A (es) Composiciones en forma de comprimidos bucodispersables de temazepan
CR11872A (es) Composiciones fungicidas
EA200802364A1 (ru) Композиция для ухода за кожей и ее применение
BRPI0913574A2 (pt) composição de tratamento de acne compreendendo nanoprata e usos
CO6300844A2 (es) Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa
ATE511765T1 (de) Geschmacksfördernder fraktionierter tomatenextrakt und zusammensetzungen, die diesen enthalten
UY31484A1 (es) Piperidinas heteroaril-sustituidas
BRPI0816236A2 (pt) Peptídeo cdh3 e agente medicinal contendo o mesmo
CR9114A (es) 2-alcoxi-3,4,5-trihydroxi-alquimidas, su preparacion composicones que las contienen y su utilizacion
ATE423119T1 (de) Pyridoä2,3-düpyrimidin-derivate sowie deren herstellung und therapeutische anwendung
ATE548349T1 (de) In stellung 3 disubstituierte indol-2-on- pyridinderivate, ihre herstellung sowie ihre therapeutische anwendung
SV2006002384A (es) Pirazolo piridinas sustituidas, composiciones que las contienen, procedimiento de fabricacion y utilizacion
ES2395740T8 (es) Composiciones que comprenden estroncio y usos de las mismas en el tratamiento o prevención de la gingivitis, la periodontitis, la periodontitis como una manifestacioón de enfermedades sistémicas y las enfermedades peridontales necrotizantes
ATE531715T1 (de) 1,3-dihydro-2h-pyrroloä3.2-büpyridin-2-onderiva e,deren herstellung und deren therapeutische verwendungen
CL2009000665A1 (es) Compuestos derivados de pirrolidinilo; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de la ansiedad, depresion o ambas.
IS8559A (is) Lyfjasamsetning gegn sveppagerlum
GT200600048A (es) Pirroles sustituidos, composiciones que los contienen, proceso de fabricación y utilización.
CL2008001572A1 (es) Tableta efervescente que comprende tramadol, acetaminofeno y opcionalmente un componente que mejora el sabor y una o mas sustancias auxiliares; y su uso para tratar dolor, tal como el dolor de dientes, dolor ocasionado por un trauma, dolor post opera
CL2007002981A1 (es) Composicion farmaceutica que contiene 75 mg del isomero dextrogiro de clopidogrel y 300 mg de triflusal, util en el tratamiento de enfermedades tromboembolicas.